James Brian Windsor - 05 Dec 2024 Form 4 Insider Report for Aileron Therapeutics, Inc. (RNTX)

Role
President and CEO
Signature
/s/ James Brian Windsor
Issuer symbol
RNTX
Transactions as of
05 Dec 2024
Net transactions value
+$898
Form type
4
Filing time
09 Dec 2024, 16:09:30 UTC
Previous filing
04 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALRN Common Stock Purchase $535 +239 $2.24 239 05 Dec 2024 By son F1
transaction ALRN Common Stock Purchase $362 +161 $2.25 161 05 Dec 2024 By son F1
holding ALRN Common Stock 7,122 05 Dec 2024 Direct
holding ALRN Common Stock 225 05 Dec 2024 By son F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.